A protein called fibronectin-EDA was linked to heart muscle damage after a heart attack in an animal study. Mice genetically altered to lack FN-EDA had less heart damage after a heart attack. Researchers suggest these findings hold potential for therapies to reduce or prevent heart muscle damage after a heart attack.